Dr. DesJardin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCSF Department of Medicine
San Francisco, CA 94101
Education & Training
- University of California San Francisco School of MedicineClass of 2017
Certifications & Licensure
- CA State Medical License 2019 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1 citationsEvaluating Pregnancy Safety During Cardiology Training.Leila Haghighat, Shadi Kalantarian, Jacqueline T DesJardin, Cara N Pellegrini
JAMA Cardiology. 2024-10-01 - Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.Jia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, Joshua R Huot, Yang Bai
Arteriosclerosis, Thrombosis, and Vascular Biology. 2024-07-01 - 4 citationsInvestigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).Jacqueline T DesJardin, Noah Kime, Nicholas A Kolaitis, Richard A Kronmal, Matthew R Lammi
The Journal of Heart and Lung Transplantation. 2024-06-01
Journal Articles
- Time to End “Manels” in Clinical Trial LeadershipTracy Y Wang, Jacqueline Talea Desjardin, JAMA Internal Medicine
- Time to End “Manels” in Clinical Trial LeadershipTracy Y Wang, Jacqueline Talea Desjardin, JAMA Internal Medicine
Authored Content
- Time to End “Manels” in Clinical Trial LeadershipAugust 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: